BCL2 and diffuse large B-cell lymphoma: Like HL, elevated levels of certain biomarkers, such as γH2AX and 8-OHdG, were associated with aggressive subtypes of DLBCL, particularly those positive for MYC/BCL2, including the Activated B-cell (ABC) subtype and high-grade B-cell lymphoma (HG-BCL).